The Effect of Four Different Methods Used During Body Weight Measurement in Newborns on Comfort and Physiological Variables

NCT07410910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2026-03-05

No results posted yet for this study

Summary

The study, planned to be conducted in a single-center, parallel-armed, randomized experimental design, aims to determine the effect of four different methods (Routine Care, Holding, Swaddling, Swaddling + Holding) on comfort scores as the primary outcome and on heart rate (HR) and peripheral capillary oxygenation (SaPO2) as secondary outcomes.

Research hypotheses

Primary Hypothesis:

H1/1: There is a difference between the mean comfort scores of the groups.

Secondary Hypothesis:

H1/2: There is a difference between the mean HR values of the groups. H1/3: There is a difference between the mean SaPO2 values of the groups.

Conditions

  • Healthy Newborns
  • Comfort in Neonates

Interventions

OTHER

Routine Care

Resetting the scale, safely placing the newborn on the baby scale, weighing them, and removing them from the scale

BEHAVIORAL

Swaddling

Swaddling: Swaddling the newborn using a safe technique, resetting the scale, safely placing the newborn on the baby scale, weighing them, and removing them from the scale.

OTHER

Holding

Holding the baby: The parent safely holding the newborn, resetting the scale, weighing the newborn on the parent's lap on an adult scale, and then the parent stepping onto the adult scale and being weighed.

BEHAVIORAL

Swaddling + Holding

Swaddling + Holding: Swaddling the newborn using a safe technique, the parent safely holding the newborn, resetting the scale, weighing the newborn on an adult scale while in the parent's arms, and only the parent stepping on the adult scale and being weighed.

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Principal Investigators

  • GUZIDE UGUCU, RN, MScN, PhD · Mersin University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-13
Primary Completion
2026-03-03
Completion
2026-03-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07410910 on ClinicalTrials.gov